Patient Adherence

Selected news for the healthcare topic - Patient Adherence, collected since 10/2017. This healthcare topic shares news with Patient Engagement, Medication Adherence, Digital Health, COVID-19, Omnicell and over a hundred others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
10/16/2021 MobileSmith Health Enhances PeriOp Surgical Patient Management Solution for ASCs to Meet Nation's Rising Demand for Outpatient Surgeries portlandnews.net ... to grow , MobileSmith is adding new enhancements to their PeriOp surgical patient solution. Targeted specifically at the ASC sector, these improvements will include Dynamic Patient Questionnaires and Omni-Channel Communications to help ASCs drive patient adherence in an effort to reduce cancellations and complications across episodes of care.'With the rising volume of outpatient surgeries across the country, the need for efficient and safe management of patients has never been ...
10/15/2021 The Ridgway Record ridgwayrecord.com ... to grow , MobileSmith is adding new enhancements to their PeriOp surgical patient solution. Targeted specifically at the ASC sector, these improvements will include Dynamic Patient Questionnaires and Omni-Channel Communications to help ASCs drive patient adherence in an effort to reduce cancellations and complications across episodes of care."With the rising volume of outpatient surgeries across the country, the need for efficient and safe management of patients has never been ...
10/15/2021 Platform improvements designed to enhance perioper wapakdailynews.com ... to grow , MobileSmith is adding new enhancements to their PeriOp surgical patient solution. Targeted specifically at the ASC sector, these improvements will include Dynamic Patient Questionnaires and Omni-Channel Communications to help ASCs drive patient adherence in an effort to reduce cancellations and complications across episodes of care."With the rising volume of outpatient surgeries across the country, the need for efficient and safe management of patients has never been ...
10/4/2021 Clalit HMO, Octopus.Health and IQVIA Introduce an AI-based Platform to Improve Patient Adherence to Treatment tncontentexchange.com NEW YORK, Oct. 4, 2021 /PRNewswire/ -- Quality healthcare outcomes largely depend on patient adherence to recommended treatment regimens. Even more so when treating patients with chronic and complex conditions. Data from Clalit, Israel's largest HMO, shows that approximately 50% of its chronic patients do not adhere to their recommended medical treatment, thus hindering care outcomes. A collaboration between Clalit HMO, IQVIA and Octopus.Health , a start-up co-founded by Clalit ...
9/29/2021 How to overcome cultural barriers for effective patient communication - NewsBreak newsbreak.com Effective communication is imperative for patient adherence , it increases patient outcomes, and it reduces malpractice risks. Dr. Janette Pepper reviews how culture can act as a barrier to effective communication and what ODs can do to overcome that barrier ...
9/23/2021 Global Obstructive Lung Disease Management Markets 2021: Opportunities Led by Big Pharma and Medical Device Companies and New Collaborations in Developing Affordable and Quality-Driven Treatments Globe Newswire ... obstructive lung disease management. The publisher has identified new therapies across six areas of high interest and growth: small molecules, biologics, gene therapy, stem cell therapy, ribonucleic acid (RNA) therapy, and combination therapies. Poor patient adherence and the lack of continuous tracking systems to monitor improvements have resulted in low outcomes. Along with newer therapeutics, advanced technologies, such as smart inhalers, and the use of digital therapeutics can enhance self ...
9/23/2021 Global Obstructive Lung Disease Management Markets 2021: Globe Newswire ... obstructive lung disease management.The publisher has identified new therapies across six areas of high interest and growth: small molecules, biologics, gene therapy, stem cell therapy, ribonucleic acid (RNA) therapy, and combination therapies.Poor patient adherence and the lack of continuous tracking systems to monitor improvements have resulted in low outcomes. Along with newer therapeutics, advanced technologies, such as smart inhalers, and the use of digital therapeutics can enhance self ...
9/23/2021 Research Efforts Fuel the Future of Global Obstructive Lung Disease Management Markets – ResearchAndMarkets.com | Financial Buzz financialbuzz.com ... obstructive lung disease management.The publisher has identified new therapies across six areas of high interest and growth: small molecules, biologics, gene therapy, stem cell therapy, ribonucleic acid (RNA) therapy, and combination therapies.Poor patient adherence and the lack of continuous tracking systems to monitor improvements have resulted in low outcomes. Along with newer therapeutics, advanced technologies, such as smart inhalers, and the use of digital therapeutics can enhance self ...
9/22/2021 Research Efforts Fuel the Future of Global Obstructive Lung Disease Management Markets - ResearchAndMarkets.com - Stocks News Feed stocksnewsfeed.com ... obstructive lung disease management.The publisher has identified new therapies across six areas of high interest and growth: small molecules, biologics, gene therapy, stem cell therapy, ribonucleic acid (RNA) therapy, and combination therapies.Poor patient adherence and the lack of continuous tracking systems to monitor improvements have resulted in low outcomes. Along with newer therapeutics, advanced technologies, such as smart inhalers, and the use of digital therapeutics can enhance self ...
9/22/2021 Research Efforts Fuel the Future of Global Obstructive Lung Disease Management Markets - ResearchAndMarkets.com Business Wire ... obstructive lung disease management. The publisher has identified new therapies across six areas of high interest and growth: small molecules, biologics, gene therapy, stem cell therapy, ribonucleic acid (RNA) therapy, and combination therapies. Poor patient adherence and the lack of continuous tracking systems to monitor improvements have resulted in low outcomes. Along with newer therapeutics, advanced technologies, such as smart inhalers, and the use of digital therapeutics can enhance self ...
9/20/2021 Extraocular, Periocular And Intraocular Routes Physicians Weekly Although once daily anti-glaucoma drug therapy is a current clinical reality, most therapies require multiple dosing and there is an unmet need to develop convenient, safe, and effective sustained release drug delivery systems for long-term treatment to improve patient adherence and outcomes. One of the first sustained release drug delivery systems was approved for the reduction of intraocular pressure in glaucoma patients. It is a polymeric reservoir-type ...
9/14/2021 The MM+M Podcast with Pleio mmm-online.com ... designed to partner with pharmacies and utilize non-HCPs to provide patient guidance outside of the clinical setting to navigate through the complexities and challenges of medication management. This podcast examines the issues around patient adherence and how it impacts pharma brands and what pharma can do to assure better patient engagement and retention ...
9/11/2021 ERLEADA® (apalutamide) Oral Presentations Demonstrate Importance of Prostate Specific Antigen (PSA) as Key Efficacy Indicator and Show Strong Patient Adherence Rates PR Newswire RARITAN, N.J. , Sept. 11, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data demonstrating robust prostate-specific antigen (PSA) response and strong adherence rates in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) treated with ERLEADA ® (apalutamide) in the real-world clinical setting. The strong PSA response was also seen in a separate post-hoc analysis that showed a correlation between rapid and deep ...
9/9/2021 Tactile Medical acquires International Biophysics’ AffloVest business medicaldevice-network.com ... and cystic fibrosis. Tactile Medical noted that the device was demonstrated to lower the use of antibiotics, emergency room visits and hospital admissions. Furthermore, AffloVest’s design offers freedom and mobility meant to enhance patient adherence . AffloVest is expected to strategically complement Tactile Medical and is in line with the company’s focus on at-home treatments for patients with underserved chronic diseases. Tactile Medical president and CEO Dan Reuvers ...
9/8/2021 New Internal Survey Shows Strength of Relationship Between GoodRx and Healthcare Providers Business Wire ... have utilized GoodRx and found they reported the following benefits of GoodRx: - Improves patient access to medication: 93% of providers surveyed say they believe that GoodRx’s savings solutions help with medication access. - Increases patient adherence : 88% of providers surveyed say they believe that GoodRx helps patients with patient adherence by helping them start and stay on their medications. - Reduces administrative burden: 89% of providers surveyed say GoodRx saves them ...
9/8/2021 CORRECTING and REPLACING New Internal Survey Shows Strength of Relationship Between GoodRx and Healthcare Providers | Business Wire Business Wire ... have utilized GoodRx and found they reported the following benefits of GoodRx:Improves patient access to medication: 93% of providers surveyed say they believe that GoodRx’s savings solutions help with medication access. Increases patient adherence : 88% of providers surveyed say they believe that GoodRx helps patients with patient adherence by helping them start and stay on their medications. Reduces administrative burden: 89% of providers surveyed say GoodRx saves them ...
9/8/2021 Patient Adherence and Compliance Market Growth and Challenges by 2027|AdhereTech., DrFirst, HCL Technologies Limited weeklywall.com Los Angeles, United States- The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Patient Adherence and Compliance market. It sheds light on how the global Patient Adherence and Compliance Market is expected to grow during the course of the forecast period. With SWOT analysis and Porter’s Five Forces analysis, it gives a deep explanation of the strengths and ...
9/6/2021 New Strategies to Improve Patient Adherence to Medications for Noncommunicable Diseases During and After the COVID-19 Era Identified via a Literature Review dovepress.com Back to Journals » Journal of Multidisciplinary Healthcare » Volume 14 New Strategies to Improve Patient Adherence to Medications for Noncommunicable Diseases During and After the COVID-19 Era Identified via a Literature Review Authors Hassan TA, Sáenz JE, Ducinskiene D, Cook JP, Imperato JS , Zou KH Received 31 March 2021 Accepted for publication 28 June ...
9/3/2021 Evidence-Based Strategies Needed to Improve Outcomes for Patients Hospitalized With Gout – An Interview With Dr Brian LaMoreaux rheumatologyadvisor.com ... Alliance of Associations for Rheumatology (EULAR) recommends a treat-to-target approach to lower serum urate levels to 5 to 6 mg/dL to prevent deposition of monosodium urate crystals.2 Despite these guidelines, patient adherence to urate-lowering therapy (ULT) has been poor.3 Between 1993 and 2011, hospitalizations for gout flares doubled from 4.4 to 8.8 admissions per 100,000 adults, respectively.4 However, hospitalizations provide an opportunity to ...
9/3/2021 FDA approves twice-yearly schizophrenia treatment healio.com ... trial investigator, said in the release. “The phase 3 trial results provide compelling evidence that 6-month paliperidone palmitate offers longer-term symptom control with the fewest doses per year, which may support greater patient adherence .” Study results showed common adverse reactions (with an incidence of at least 5%) to the treatment included respiratory tract infections, injection site reactions, weight increase, headaches and parkinsonism (12%, 11%, 9%, 7% and ...